Literature DB >> 1086857

Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis.

J G Haddad, J Walgate.   

Abstract

A radioimmunoassay for the binding protein for vitamin D and its metabolites (DBP) has been developed. Suitable rabbit anti-DBP antiserum was elicited after primary and one booster injection. Anti-DBP antisera, as well as antigroup-specific component antisera, produced a single, monospecific line of percipitation when reacted against purified DBP and human serum. DBP was iodinated with 125I and 125I-DBP was purified by gel filtration on Sephadex G-200. Binding of 125I-DBP by 20 nl of rabbit anti-DBP antisera was approximately 50% and was sharply competed for by 0.4-4.0 ng of DBP standard. Displacement of 125I-DBP by human serum dilutions or standard DBP gave identical curves, and only weak competition was observed with old and new world primate sera. Apo- and holo-DBP possessed indistinguishable immunoreactivity. The assay detects DBP in 1-10 nl of human serum with reasonable accuracy and with reasonable intra- and interassay precision. The mean serum concentration (+/- SEM) for a group of 40 normal adults was 525 +/- 24 mug/ml and no sex difference was observed. Higher levels were found in sera from pregnant women and women receiving oral contraceptives, and decreased concentrations were observed in premature cord and hypoproteinemic sera. No significant correlation between serum DBP levels and serum 25-hydroxycalciferol levels was found, and the DBP content of sera from vitamin D-deprived and vitamin D-treated subjects was indistinguishable from that of normal adults. DBP accounts for 6- of the alpha globulin in normal human serum. Considering the normal serum content of the parent vitamin and its metabolites to be approximately 0.1-0.2 mum, these immunoassay data confirm previous saturation analyses of human serum antiricketic sterol-binding capacity and suggest that greater than 95% of DBP circulates as the apoprotein under normal conditions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086857      PMCID: PMC333290          DOI: 10.1172/JCI108575

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Circulating 25-hydroxyvitamin D in man.

Authors:  J G Haddad; T C Stamp
Journal:  Am J Med       Date:  1974-07       Impact factor: 4.965

3.  Measurement of plasma 25-hydroxycholecalciferol in man.

Authors:  F Bayard; P Bec; J P Louvet
Journal:  Eur J Clin Invest       Date:  1972-06       Impact factor: 4.686

4.  The distribution and storage of vitamin D and its metabolites in human tissues.

Authors:  E B Mawer; J Backhouse; C A Holman; G A Lumb; S W Stanbury
Journal:  Clin Sci       Date:  1972-09       Impact factor: 6.124

5.  Competitive protein-binding radioassay for 25-hydroxycholecalciferol.

Authors:  J G Haddad; K J Chyu
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

Review 6.  The variants of the group-specific component. A review of their distribution in human populations.

Authors:  H Cleve
Journal:  Isr J Med Sci       Date:  1973 Sep-Oct

7.  Detection of nanogram quantities of vitamin D by gas-liquid chromatography.

Authors:  L V Avioli; S W Lee
Journal:  Anal Biochem       Date:  1966-08       Impact factor: 3.365

8.  Interactions of plasma retinol-binding protein with its receptor. Specific binding of bovine and human retinol-binding protein to pigment epithelium cells from bovine eyes.

Authors:  J Heller
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

9.  Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D.

Authors:  S P Daiger; M S Schanfield; L L Cavalli-Sforza
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

10.  The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma.

Authors:  J E Smith; D S Goodman
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

View more
  26 in total

1.  Uptake and degradation of filamentous actin and vitamin D-binding protein in the rat.

Authors:  S Dueland; M S Nenseter; C A Drevon
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

2.  Abnormal vitamin D metabolism in cirrhosis.

Authors:  R T Jung; M Davie; J O Hunter; T M Chalmers; D E Lawson
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

3.  Uptake and degradation of vitamin D binding protein and vitamin D binding protein-actin complex in vivo in the rat.

Authors:  S Dueland; R Blomhoff; J I Pedersen
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

Review 4.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

5.  Vitamin D metabolism in acute and chronic cholestasis.

Authors:  R T Jung; M Davie; P Siklos; T M Chalmers; J O Hunter; D E Lawson
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

6.  Quantitative studies of the interaction of cholecalciferol ((vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols.

Authors:  M Kawakami; M Imawari; D S Goodman
Journal:  Biochem J       Date:  1979-05-01       Impact factor: 3.857

7.  First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.

Authors:  Camille E Powe; Ellen W Seely; Sarosh Rana; Ishir Bhan; Jeffrey Ecker; S Ananth Karumanchi; Ravi Thadhani
Journal:  Hypertension       Date:  2010-08-23       Impact factor: 10.190

8.  Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults.

Authors:  Jennifer S Sonderman; Heather M Munro; William J Blot; Lisa B Signorello
Journal:  Am J Epidemiol       Date:  2012-09-13       Impact factor: 4.897

9.  Serum concentrations of vitamin D-binding protein (group-specific component) in cystic fibrosis.

Authors:  D Coppenhaver; F Kueppers; D Schidlow; D Bee; J N Isenburg; D R Barnett; B H Bowman
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

10.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

Authors:  D D Bikle; E Gee; B Halloran; J G Haddad
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.